| 000 | 01570 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250517125209.0 | ||
| 264 | 0 | _c20180521 | |
| 008 | 201805s 0 0 eng d | ||
| 022 | _a2045-2322 | ||
| 024 | 7 |
_a10.1038/srep37585 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKritikou, Eva | |
| 245 | 0 | 0 |
_aInhibition of lysophosphatidic acid receptors 1 and 3 attenuates atherosclerosis development in LDL-receptor deficient mice. _h[electronic resource] |
| 260 |
_bScientific reports _c11 2016 |
||
| 300 |
_a37585 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAtherosclerosis _xblood |
| 650 | 0 | 4 |
_aCholesterol, LDL _xblood |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aEndocytosis _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIsoxazoles _xadministration & dosage |
| 650 | 0 | 4 |
_aLysophospholipids _xgenetics |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aPropionates _xadministration & dosage |
| 650 | 0 | 4 |
_aReceptors, LDL _xdeficiency |
| 650 | 0 | 4 |
_aReceptors, Lysophosphatidic Acid _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aSignal Transduction _xgenetics |
| 700 | 1 | _avan Puijvelde, Gijs H M | |
| 700 | 1 | _avan der Heijden, Thomas | |
| 700 | 1 | _avan Santbrink, Peter J | |
| 700 | 1 | _aSwart, Maarten | |
| 700 | 1 | _aSchaftenaar, Frank H | |
| 700 | 1 | _aKröner, Mara J | |
| 700 | 1 | _aKuiper, Johan | |
| 700 | 1 | _aBot, Ilze | |
| 773 | 0 |
_tScientific reports _gvol. 6 _gp. 37585 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/srep37585 _zAvailable from publisher's website |
| 999 |
_c26636694 _d26636694 |
||